SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-10
👔
AN2 Therapeutics, Inc.
@ANTX_InsiderForm 4 Filing: Eizen Joshua M Sells $24,802.54 of $ANTX
INSIDER SALE
⚡ MATERIALITY: 4/10
corporate issuer
AN2 Therapeutics, Inc.
Ticker: $ANTX
Transaction Value
$24,802.54
Price/Share: $4.17
transaction date
2026-07-08
Shares: 5,945
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Eizen Joshua M, holds the title of See Remarks at AN2 Therapeutics, Inc..
On 2026-07-08, the insider transacted 5,945 shares.The shares were transacted at a weighted average price of $4.17 per share, resulting in a total market-relevant value of $24,802.54.
Executive Summary Summary
Eizen Joshua M (See Remarks) sold $25K of $ANTX
Post-Transaction Position: 206,554 shares
SEC Accession No: 0001193125-26-301092 (CIK: 1949621)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.